[Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer]
- PMID: 17991318
[Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer]
Abstract
Background & objective: CpG island hypermethylation in promoter region of E-cadherin (E-cad) gene plays an important role in tumorigenesis of many tumors. This study was to explore the correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer.
Methods: Methylation-specific polymerase chain reaction (MSP) was used to detect the methylation of E-cad gene in 41 specimens of gastric cancer, 40 specimens of premalignant gastric lesions and 38 specimens of normal gastric tissues. The expression of E-cad protein was detected by SP immunohistochemistry.
Results: The positive rate of E-cad gene methylation was significantly higher in gastric cancer than in premalignant lesions and normal tissues (19.5% vs. 2.5% and 0.0%, P<0.05). The positive rate of E-cad protein was significantly lower in gastric cancer tissues than in premalignant lesions and normal tissues (70.7% vs. 97.5% and 100.0%, P<0.05). The positive rate of E-cad gene methylation was significantly higher in poorly differentiated cancer tissues than in well differentiated cancer tissues (43.8% vs. 4.0%, P<0.05), significantly higher in gastric cancer tissues with lymph node metastasis than in those without lymph node metastasis (33.3% vs. 5.0%, P<0.05), and significantly higher in gastric cancer tissues with serosa invasion than in those without serosa invasion (35.0% vs. 4.8%, P<0.05). The positive rate of E-cad protein was significantly lower in gastric cancer tissues with E-cad gene methylation than in those without E-cad gene methylation (0.0% vs. 87.9%, P<0.05).
Conclusion: CpG island hypermethylation of E-cad gene exists in gastric cancer, which down-regulates E-cad expression and might be involved in tumorigenesis and development of gastric cancer.
Similar articles
-
[CpG island methylation of E-cadherin gene promoter in gastric carcinoma].Ai Zheng. 2005 Oct;24(10):1220-4. Ai Zheng. 2005. PMID: 16219136 Chinese.
-
E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis.J Surg Oncol. 2007 Oct 1;96(5):429-35. doi: 10.1002/jso.20732. J Surg Oncol. 2007. PMID: 17786966
-
Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.Hum Pathol. 2009 Nov;40(11):1534-42. doi: 10.1016/j.humpath.2009.01.029. Epub 2009 Aug 19. Hum Pathol. 2009. PMID: 19695681
-
CpG island hypermethylation in progression of esophageal and gastric cancer.Cancer. 2006 Feb 1;106(3):483-93. doi: 10.1002/cncr.21657. Cancer. 2006. PMID: 16362978 Review.
-
[From gene to disease; E-cadherin and hereditary diffuse gastric cancer].Ned Tijdschr Geneeskd. 2003 Dec 13;147(50):2474-7. Ned Tijdschr Geneeskd. 2003. PMID: 14708213 Review. Dutch.
Cited by
-
Epigenetic alterations in gastric cancer (Review).Mol Med Rep. 2015 Sep;12(3):3223-3230. doi: 10.3892/mmr.2015.3816. Epub 2015 May 22. Mol Med Rep. 2015. PMID: 25997695 Free PMC article. Review.
-
Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.Pathol Oncol Res. 2018 Oct;24(4):757-770. doi: 10.1007/s12253-018-0410-z. Epub 2018 Mar 19. Pathol Oncol Res. 2018. PMID: 29552712 Review.
-
Epigenetics: an emerging player in gastric cancer.World J Gastroenterol. 2014 Jun 7;20(21):6433-47. doi: 10.3748/wjg.v20.i21.6433. World J Gastroenterol. 2014. PMID: 24914365 Free PMC article. Review.
-
Epigenetic contributions to cancer metastasis.Clin Exp Metastasis. 2009;26(1):5-18. doi: 10.1007/s10585-008-9166-2. Epub 2008 Apr 2. Clin Exp Metastasis. 2009. PMID: 18386135
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous